JP TSE 4584 Pharmaceutical

Kidswell Bio Corporation

キッズウェル・バイオ株式会社

Fiscal year ends
Mar
Latest results
FY ending Mar 2026 (consolidated)
Employees
32
Revenue
¥6.6B
≈ $41.7M
Net income
−¥414M
≈ −$2.6M
Income taxes paid
¥152M
≈ $962K
Total assets
¥6.1B
≈ $38.5M
Equity ratio
27.2%
 

Ranked #2,947 among listed Japanese companies by corporate taxes paid.

Share price at fiscal year-end: ¥243 · market capitalization ¥12.1B · P/E 41.2 · P/B 7.29

US dollar amounts use ¥158.0 per dollar.

Annual results

Fiscal yearRevenueNet incomeTax expenseTaxes paidTotal assetsNet assetsEquity ratioSource
Mar 2026¥6.6B−¥414M ¥11.1M¥152M ¥6.1B¥1.7B27.2% EDINET (consol.)
Mar 2025¥5.1B−¥21.1M ¥94.0M¥1.6M ¥7.0B¥1.4B20.1% EDINET (consol.)
Mar 2024¥2.4B−¥1.4B —— ¥5.1B¥831M16.3% EDINET
Mar 2023¥2.8B−¥657M —— ¥3.9B¥1.2B31.7% EDINET
Mar 2022¥1.6B−¥535M —— ¥3.5B¥1.7B49.1% EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ(同業比較・役員)

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.

World rankings